Suchergebnisse - "Ishige, Takayuki"

PubPharm (10)

1

An LC/MS/MS method for quantifying testosterone and dehydroepiandrosterone sulfate in four different serum samples during a single run

enthalten in: Analytical sciences | 2022

von Fujimura, S. | Ito, T. | Ogawa, S. | +3

2

Development and validation of the simultaneous measurement of four vitamin D metabolites in serum by LC–MS/MS for clinical laboratory applications

enthalten in: Analytical & bioanalytical chemistry | 2016

von Satoh, M. | Ishige, T. | Ogawa, S. | +4

3

Locked nucleic acid probe enhances Sanger sequencing sensitivity and improves diagnostic accuracy of high-resolution melting-based KRAS mutational analysis

enthalten in: Clinica chimica acta | 2016

von Ishige, T. | Itoga, S. | Matsushita, K. | +1

4

Detection of Ubiquitinated Dermcidin in Gingival Crevicular Fluid in Periodontal Disease

enthalten in: International journal of peptide research and therapeutics | 2015

von Tsuchida, S. | Satoh, M. | Takiwaki, M. | +6

5

Alternative Splicing Detection as a Biomarker for Cancer Diagnosis : A Novel Progressive Mechanism of Acute Lymphoblastic Leukemia with Alternative Splicing as a Biomarker Candidate

enthalten in: Rinsho byori. The Japanese journal of clinical pathology | 2015

von Kitamura, K. | Matsushita, K. | Kobayashi, S. | +10

6

Assessment of Vitamin D Metabolism by LC-MS/MS

enthalten in: Rinsho byori. The Japanese journal of clinical pathology | 2015

von Ishige, T. | Satoh, M. | Ogawa, S. | +3

7

Serum cytokine and chemokine profiles in patients with chronic inflammatory demyelinating polyneuropathy

enthalten in: Journal of neuroimmunology | 2015

von Beppu, M. | Sawai, S. | Misawa, S. | +6

8

Application of proteomic technologies to discover and identify biomarkers for periodontal diseases in gingival crevicular fluid: A review

enthalten in: Proteomics / Clinical applications | 2014

von Tsuchida, S. | Satoh, M. | Sogawa, K. | +9

9

Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): A highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

enthalten in: Bioorganic & medicinal chemistry | 2012

von Yoshida, T. | Akahoshi, F. | Sakashita, H. | +27

10

Potential of synchrotron X-ray powder diffractometry for detection and quantification of small amounts of crystalline drug substances in pharmaceutical tablets

enthalten in: Journal of pharmaceutical and biomedical analysis | 2011

von Yamada, H. | Masuda, K. | Ishige, T. | +5

1
[1]